A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2011
11/03/2011	US20110269830 Statin nanoparticles
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269799 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269786 Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies
11/03/2011	US20110269785 Substituted 2-Aminoacetamides and the Use Thereof
11/03/2011	US20110269780 Aza-benzimidazolone chymase inhibitors
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269772 Axl kinase inhibitors
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269762 Methods for treating atrial fibrillation and reducing stroke rate in atrial fibrillation patients
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269758 Naphthyridinones as protein kinase inhibitors
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269755 Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
11/03/2011	US20110269747 Polyarylcarboxamides useful as lipid lowering agents
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269739 Kinase inhibitors
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269735 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
11/03/2011	US20110269734 Piperidinyl gpcr agonists
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269715 Abnormal cannabidiols as agents for lowering intraocular pressure
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269701 7,2''-dehydrate puerarin and its salts, preparation method and use thereof
11/03/2011	US20110269700 Glucoside derivatives and uses thereof
11/03/2011	US20110269685 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
11/03/2011	US20110269684 Natriuretic polypeptides for reducing or preventing restenosis
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	US20110269667 Methods of generating and using procollagen
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268824 Composition for preventing or treating artherosclerosis
11/03/2011	US20110268814 Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease
11/03/2011	US20110268808 Dual-release pharmaceutical suspension
11/03/2011	US20110268797 Multicoated aliskiren formulations
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268774 preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof
11/03/2011	US20110268771 Chewable gelled emulsions
11/03/2011	US20110268770 Chewable gelled emulsions
11/03/2011	US20110268768 Compositions and Methods for Treating Atherosclerosis
11/03/2011	US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/03/2011	US20110268719 Annatto Extract Compositions, Including Geranyl Geraniols And Methods Of Use
11/03/2011	US20110268714 CD34 Stem Cell-Related Methods and Compositions
11/03/2011	US20110268713 Variants of Ancestral Uricases and Uses Thereof
11/03/2011	US20110268710 Methods of treating stroke using stem cell-like menstrual blood cells
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268708 Adipose tissue-derived stem cells for veterinary use
11/03/2011	US20110268702 Lactobacillus paracasei and weight control
11/03/2011	US20110268694 Methods for treating vascular leak syndrome
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	US20110268658 Polymer-agent conjugates, particles, compositions, and related methods of use
11/03/2011	CA2794824A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011	CA2793856A1 Tetrahydrobenzothiophene compound
11/02/2011	EP2383336A1 Peptide capable of binding to immunoglobulin
11/02/2011	EP2383272A1 Active blood coagulation factor inhibitor
11/02/2011	EP2383269A2 Substituted Dihydropyrazolones for the treatment of cardiovascular diseases
11/02/2011	EP2383263A2 Novel thiazolidinedione derivative and use thereof
11/02/2011	EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011	EP2382982A2 Neural regeneration peptide and methods for their use in treatment of brain damage
11/02/2011	EP2382203A1 Bicyclic heterocycle derivatives and methods of use thereof
11/02/2011	EP2382194A2 Compounds for the prevention and treatment of cardiovascular disease
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	EP2276504B1 Medicament and formulations thereof for use in reducing or preventing atherosclerosis
11/02/2011	EP2185550B1 Substituted aryloxazoles and the use thereof
11/02/2011	EP1924585B1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
11/02/2011	EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011	EP1535913B1 Novel quaternary ammonium compounds
11/02/2011	EP1386165B1 Inflammatory markers for detection and prevention of diabetes mellitus
11/02/2011	CN1981752B Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
11/02/2011	CN102232084A Neuregulin peptides and their use
11/02/2011	CN102231987A Neuregulin and cardiac stem cells
11/02/2011	CN102229924A Polyethylene glycol-modified Serratia protein-digesting enzyme as well as preparation method and application thereof
11/02/2011	CN102229911A Sca-1+/CD34- uterine stem cells and separation method thereof
11/02/2011	CN102229668A GLP-1 (glucagon-like peptide-1) derivative and application thereof
11/02/2011	CN102229658A Anti-rheumatoid arthritis polypeptide and its application in pharmacy
11/02/2011	CN102229657A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229656A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229655A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229654A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229653A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229652A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229602A Tacrine heterocomplex, preparation method and use in medicines for curing neurodegenerative diseases thereof
11/02/2011	CN102229601A Hexahydro-1-(5-isoquinoline sulfonyl)-1 (H)-1, 4- diazepine hydrochloride amorphous compound
11/02/2011	CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors
11/02/2011	CN102229572A 3-fluorophenyl-quinazoline-4 (3H)-ketone compound and preparation method thereof
11/02/2011	CN102229562A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
11/02/2011	CN102229528A Method for extracting unsaturated fatty acid composition from humen amniotic epithelial cells, and application thereof
11/02/2011	CN102228697A Application of microRNA (Ribonucleic Acid)-26 in preparing medicament for preventing and treating atrial fibrillation
11/02/2011	CN102228691A Aspirin and anticoagulant pharmaceutical composition
11/02/2011	CN102228682A Medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues
11/02/2011	CN102228658A Medicament for treating arteriosclerotic cerebral infarction and preparation method thereof
11/02/2011	CN102228640A Medicine for treating hemiplegia
11/02/2011	CN102228618A Chinese medicinal powder for treating ischemic heart disease

1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 1595